Skip to main content
Fig. 6 | Critical Care

Fig. 6

From: A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients

Fig. 6

Change in quadriceps strength (QuadTw) between initial and post-treatment measurements is presented for the four experimental groups in the top panel (same format as in Fig. 5). The mean difference for quadriceps twitch force pre- and post-treatment was 2.26 (95% CI − 0.51 to 5.0), 1.12 (95% CI − 0.34 to 2.59), 0.26 (95% CI − 3.01 to 3.57), and 0.18 (95% CI − 2.07 to 2.43), respectively, for Control, EPA, HMB, and HMB + EPA groups (p = 0.535). As a result, there was no significant difference in changes in quadriceps strength over time between the four experimental groups. Change in quadriceps thickness between initial and post-treatment measurements is presented for the four experimental groups in the bottom panel. The mean difference for quadriceps twitch thickness pre- and post-treatment was − 0.08 (95% CI − 0.39 to 0.23), − 0.33 (95% CI − 0.77 to 0.11), − 0.34 (95% CI − 0.74 to 0.06), and − 0.15 (95% CI − 0.58 to 0.27), respectively, for Control, EPA, HMB, and HMB + EPA groups (p = 0.647). As a result, there was no significant difference in changes in quadriceps thickness over time between the four experimental groups

Back to article page

Critical Care

ISSN: 1364-8535